The Diagnostic Efficacy of Version 2018 LI-RADS for Hepatocellular Carcinoma on Enhanced Magnetic Resonance Imaging
Objectives: To evaluate the diagnostic performance of the 2018 version of liver reporting and date system (LI-RADS v2018) for hepatocellular carcinoma (HCC) on contrast-enhanced magnetic resonance imaging (MRI) in high-risk patients. Methods: The data from 69 patients with HCC confirmed by pathology...
Main Authors: | Sulan JIA, Jingbo DU, Xiaohua SU |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of Computerized Tomography Theory and Application
2023-01-01
|
Series: | CT Lilun yu yingyong yanjiu |
Subjects: | |
Online Access: | https://www.cttacn.org.cn/cn/article/doi/10.15953/j.ctta.2023.073 |
Similar Items
-
MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018
by: Haiping Zhang, et al.
Published: (2022-04-01) -
Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC
by: Rong Wen, et al.
Published: (2023-09-01) -
FI-CEUS: a solution to improve the diagnostic accuracy in MRI LI-RADS-indeterminate (LR-3/4) FLLs at risk for HCC
by: Qingjing Zeng, et al.
Published: (2024-01-01) -
Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
by: Peihua Wang, et al.
Published: (2021-12-01) -
Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
by: Li Y, et al.
Published: (2023-03-01)